Karyopharm Therapeutics Inc. Shares Outstanding (Cover Page)
Karyopharm Therapeutics Inc. (KPTI) had Shares Outstanding (Cover Page) of 22.68 million shares as of 2026-08-06, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-06: Entity Common Stock, Shares Outstanding 22.68M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 22.66M shares.
- 2026-02-05: Entity Common Stock, Shares Outstanding 18.34M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 17.05B shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 22.68M shares 10-Q · filed 2026-08-13 |
| 2026-05-07 | 22.66M shares 10-Q · filed 2026-05-14 |
| 2026-02-05 | 18.34M shares 10-K · filed 2026-02-13 |
| 2025-10-30 | 17.05B shares 10-Q · filed 2025-11-03 |
| 2025-08-06 | 8.67M shares 10-Q · filed 2025-08-11 |
| 2025-05-07 | 8.64M shares 10-Q · filed 2025-05-12 |
| 2025-02-14 | 126.24M shares 10-K · filed 2025-02-19 |
| 2024-10-31 | 125.31M shares 10-Q · filed 2024-11-05 |
| 2024-07-31 | 124.68M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 117.71M shares 10-Q · filed 2024-05-08 |
| 2024-02-23 | 115.07M shares 10-K · filed 2024-02-29 |
| 2023-10-27 | 114.53M shares 10-Q · filed 2023-11-02 |
| 2023-07-28 | 114.35M shares 10-Q · filed 2023-08-02 |
| 2023-04-28 | 114.01M shares 10-Q · filed 2023-05-04 |
| 2023-02-10 | 113.34M shares 10-K · filed 2023-02-17 |
| 2022-10-28 | 81.16M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 79.81M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 79.42M shares 10-Q · filed 2022-05-05 |
| 2022-02-22 | 79.16M shares 10-K · filed 2022-03-01 |
| 2021-10-27 | 75.55M shares 10-Q · filed 2021-11-03 |
| 2021-07-28 | 75.50M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 75.09M shares 10-Q · filed 2021-05-04 |
| 2021-02-16 | 74.63M shares 10-K · filed 2021-02-24 |
| 2020-10-28 | 73.60M shares 10-Q · filed 2020-11-02 |
| 2020-07-30 | 73.48M shares 10-Q · filed 2020-08-04 |
| 2020-04-30 | 73.12M shares 10-Q · filed 2020-05-05 |
| 2020-02-14 | 65.55M shares 10-K · filed 2020-02-26 |
| 2019-10-29 | 62.79M shares 10-Q · filed 2019-11-04 |
| 2019-07-31 | 61.92M shares 10-Q · filed 2019-08-07 |
| 2019-04-30 | 60.86M shares 10-Q · filed 2019-05-09 |
| 2019-02-15 | 60.86M shares 10-K · filed 2019-02-28 |
| 2018-11-02 | 60.71M shares 10-Q · filed 2018-11-08 |
| 2018-08-02 | 60.56M shares 10-Q · filed 2018-08-07 |
| 2018-05-04 | 49.85M shares 10-Q · filed 2018-05-10 |
| 2018-03-09 | 49.65M shares 10-K · filed 2018-03-15 |
| 2017-10-30 | 47.18M shares 10-Q · filed 2017-11-02 |
| 2017-07-31 | 47.14M shares 10-Q · filed 2017-08-08 |
| 2017-04-28 | 47.12M shares 10-Q · filed 2017-05-04 |
| 2017-03-10 | 41.90M shares 10-K · filed 2017-03-16 |
| 2016-11-02 | 41.24M shares 10-Q · filed 2016-11-07 |
| 2016-07-31 | 35.99M shares 10-Q · filed 2016-08-04 |
| 2016-05-03 | 35.96M shares 10-Q · filed 2016-05-09 |
| 2016-03-07 | 35.88M shares 10-K · filed 2016-03-15 |
| 2015-11-04 | 35.73M shares 10-Q · filed 2015-11-09 |
| 2015-07-31 | 35.71M shares 10-Q · filed 2015-08-10 |
| 2015-04-30 | 35.69M shares 10-Q · filed 2015-05-11 |
| 2015-03-11 | 35.68M shares 10-K · filed 2015-03-13 |
| 2014-11-04 | 32.70M shares 10-Q · filed 2014-11-10 |
| 2014-07-31 | 32.67M shares 10-Q · filed 2014-08-07 |
| 2014-04-30 | 29.76M shares 10-Q · filed 2014-05-08 |
| 2014-03-14 | 29.75M shares 10-K · filed 2014-03-21 |
| 2013-12-16 | 29.75M shares 10-Q/A · filed 2013-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |